• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The relationship between renal function and surgical outcomes of patients with proliferative diabetic retinopathy.肾功能与增殖性糖尿病视网膜病变患者手术结果的关系。
Front Endocrinol (Lausanne). 2022 Aug 25;13:984561. doi: 10.3389/fendo.2022.984561. eCollection 2022.
2
A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.小切口玻璃体切割术联合或不联合玻璃体腔抗血管内皮生长因子药物预处理治疗增生型糖尿病视网膜病变的临床疗效的系统评价和荟萃分析。
Ophthalmic Res. 2023;66(1):777-790. doi: 10.1159/000530231. Epub 2023 Mar 27.
3
The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.玻璃体切割术治疗增生性糖尿病视网膜病变伴玻璃体积血前玻璃体内注射雷珠单抗的疗效和安全性。
BMC Ophthalmol. 2022 Feb 10;22(1):63. doi: 10.1186/s12886-022-02303-3.
4
Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.填塞在伴有玻璃体积血的增殖性糖尿病视网膜病变玻璃体切除术中的作用
Semin Ophthalmol. 2017;32(4):488-491. doi: 10.3109/08820538.2015.1120757. Epub 2016 Apr 29.
5
Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.玻璃体腔内注射贝伐单抗治疗严重增生性糖尿病视网膜病变的手术治疗。
Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3. Epub 2010 Feb 5.
6
A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.增生型糖尿病视网膜病变玻璃体切除术后应用黏弹剂预防玻璃体积血复发的初步研究。
BMC Ophthalmol. 2022 Dec 22;22(1):509. doi: 10.1186/s12886-022-02666-7.
7
Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.眼内 VEGF 水平作为增生型糖尿病视网膜病变玻璃体切除术后并发症的危险因素。
Invest Ophthalmol Vis Sci. 2012 Sep 21;53(10):6403-10. doi: 10.1167/iovs.12-10367.
8
The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.全身血管紧张素受体阻滞剂对增生型糖尿病视网膜病变患者玻璃体血管内皮生长因子的影响。
Curr Eye Res. 2013 Jul;38(7):774-80. doi: 10.3109/02713683.2013.772206.
9
Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.增生型糖尿病视网膜病变患者玻璃体切除术后玻璃体积血行单向空气-液体交换术后的视力结果和并发症。
BMC Ophthalmol. 2021 Mar 9;21(1):129. doi: 10.1186/s12886-021-01885-8.
10
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.视力、玻璃体积血及其他眼部结局:玻璃体切割术与阿柏西普治疗糖尿病视网膜病变玻璃体积血的比较:一项随机临床试验的二次分析。
JAMA Ophthalmol. 2021 Jul 1;139(7):725-733. doi: 10.1001/jamaophthalmol.2021.1110.

引用本文的文献

1
The influence of renal function on surgical outcomes of vitrectomy in patients with proliferative diabetic retinopathy.肾功能对增殖性糖尿病视网膜病变患者玻璃体切除手术预后的影响。
Front Endocrinol (Lausanne). 2025 Jul 16;16:1592618. doi: 10.3389/fendo.2025.1592618. eCollection 2025.
2
Renal impairment may indicate postoperative low vision in young patients with proliferative diabetic retinopathy undergoing vitrectomy.肾功能损害可能预示着接受玻璃体切除术的增殖性糖尿病视网膜病变年轻患者术后视力低下。
Front Endocrinol (Lausanne). 2024 Jan 11;14:1321226. doi: 10.3389/fendo.2023.1321226. eCollection 2023.

本文引用的文献

1
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.12. 视网膜病变、神经病变和足部护理:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S185-S194. doi: 10.2337/dc22-S012.
2
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.2. 糖尿病的分类和诊断:2022 年糖尿病医疗护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. doi: 10.2337/dc22-S002.
3
Clinical correlation of diabetic retinopathy with nephropathy and neuropathy.糖尿病视网膜病变与肾病和神经病变的临床关联
Indian J Ophthalmol. 2021 Nov;69(11):3364-3368. doi: 10.4103/ijo.IJO_1237_21.
4
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.糖尿病肾病:发病机制、诊断和治疗的挑战。
Biomed Res Int. 2021 Jul 8;2021:1497449. doi: 10.1155/2021/1497449. eCollection 2021.
5
The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies.2 型糖尿病患者糖尿病视网膜病变对随后发生糖尿病肾病的预测价值:前瞻性研究的系统评价和荟萃分析。
Ren Fail. 2021 Dec;43(1):231-240. doi: 10.1080/0886022X.2020.1866010.
6
Relationship Between Retinal Capillary Nonperfusion Area and Renal Function in Patients With Type 2 Diabetes.2 型糖尿病患者视网膜毛细血管无灌注区与肾功能的关系。
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):14. doi: 10.1167/iovs.61.14.14.
7
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy.新冠疫情期间远程医疗的重要性:以糖尿病视网膜病变为例。
J Diabetes Res. 2020 Oct 14;2020:9036847. doi: 10.1155/2020/9036847. eCollection 2020.
8
Screening for diabetic retinopathy: new perspectives and challenges.糖尿病视网膜病变筛查:新视角与新挑战。
Lancet Diabetes Endocrinol. 2020 Apr;8(4):337-347. doi: 10.1016/S2213-8587(19)30411-5. Epub 2020 Feb 27.
9
Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.康柏西普玻璃体腔内注射辅助玻璃体切除治疗增生型糖尿病视网膜病变患者玻璃体血管内皮生长因子浓度的变化
Chin Med J (Engl). 2020 Mar 20;133(6):664-669. doi: 10.1097/CM9.0000000000000687.
10
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.白蛋白尿型慢性肾脏病与 2 型糖尿病患者糖尿病视网膜病变的真实世界关联:来自 No blind 研究的结果。
Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):923-930. doi: 10.1016/j.numecd.2019.05.065. Epub 2019 Jun 7.

肾功能与增殖性糖尿病视网膜病变患者手术结果的关系。

The relationship between renal function and surgical outcomes of patients with proliferative diabetic retinopathy.

机构信息

Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Ophthalmology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Front Endocrinol (Lausanne). 2022 Aug 25;13:984561. doi: 10.3389/fendo.2022.984561. eCollection 2022.

DOI:10.3389/fendo.2022.984561
PMID:36093071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9453752/
Abstract

OBJECTIVES

The relationship between renal function and diabetic retinopathy has been controversial. This study is to investigate the influence of renal function on the complex and surgical outcomes of proliferative diabetic retinopathy (PDR).

METHODS

This was a analysis of the CONCEPT clinical trial. A total of 45 eyes with PDR underwent vitrectomy were included. Based on the estimated glomerular filtration rate (eGFR), they were divided into abnormal renal function group () and normal renal function group (). Baseline PDR complex, intraoperative outcomes (Intraoperative bleeding, frequency of endodiathermy, surgical time, iatrogenic hole, and tamponade) and postoperative outcomes (logMAR best-corrected visual acuity, vitreous re-hemorrhage, and macular edema, follow up at postoperative 1 month and 3 months) were estimated. Vitreous, aqueous humor and serum were collected at the vitrectomy day and Vascular endothelia growth factor-A levels were quantified for all included patients using liquid chip method.

RESULTS

There was no significant difference in baseline PDR complex, intraoperative and postoperative outcomes between and (all P > 0.05). At the vitrectomy day, there was also no difference of Vascular endothelia growth factor-A levels in vitreous, aqueous humor and serum between the two groups (all P > 0.05).

CONCLUSION

Our results showed that the renal function seems not parallel to the severity of PDR, neither to the surgical outcomes. This might be interpreted by the similar Vascular endothelia growth factor-A levels in vitreous, aqueous humor and serum between the two groups.

摘要

目的

肾功能与糖尿病视网膜病变之间的关系一直存在争议。本研究旨在探讨肾功能对增生性糖尿病视网膜病变(PDR)复杂病变和手术结果的影响。

方法

这是对 CONCEPT 临床试验的分析。共纳入 45 只接受玻璃体切除术的 PDR 眼。根据估算的肾小球滤过率(eGFR),将其分为肾功能异常组()和肾功能正常组()。评估基线 PDR 复杂性、术中结果(术中出血、内透热治疗频率、手术时间、医源性裂孔和填塞)和术后结果(logMAR 最佳矫正视力、玻璃体积血和黄斑水肿,术后 1 个月和 3 个月随访)。在玻璃体切除术当天收集所有纳入患者的玻璃体、房水和血清,并使用液相芯片法定量血管内皮生长因子-A 水平。

结果

和组之间在基线 PDR 复杂性、术中及术后结果方面均无显著差异(均 P > 0.05)。在玻璃体切除术当天,两组之间的玻璃体、房水和血清中的血管内皮生长因子-A 水平也无差异(均 P > 0.05)。

结论

我们的结果表明,肾功能似乎与 PDR 的严重程度不平行,也与手术结果不平行。这可能可以解释两组之间的玻璃体、房水和血清中的血管内皮生长因子-A 水平相似。